Remove 2010 Remove ACA Remove FDA
article thumbnail

Inter-Loper: Loper Bright and Judicial Intrusion on Agency Prerogatives

Bill of Health

Food and Drug Administration (FDA), and Department of Health Human Services (HHS). It may very well be that deciding when an alpha amino acid polymer is a “protein” to be regulated by the FDA is not simply a question of statutory interpretation, but also a question of science and policy. Loper Bright overturned Chevron v.

FDA 124
article thumbnail

GOP House Opens With Abortion Agenda

Kaiser Health News

On one hand, the FDA has relaxed some of the risk evaluation and mitigation strategies (REMS) from the prescribing rules surrounding abortion pills. The FDA puts these extra restrictions or safeguards in place for certain drugs to add additional protection. Some advocates say these pills simply do not bring that level or risk.